Author:
eczemarelief
Evommune ends development of lead asset in chronic hives after mid-stage efficacy woes – BioSpace
eczemarelief
June 30, 2026
Eczema affects up to 1 in 5 children worldwide, experts say – WBFF
eczemarelief
June 28, 2026
CHMP Issues Positive Opinion for Ruxolitinib Cream for Adults With Moderate AD – The Dermatology Digest
eczemarelief
June 26, 2026
Tiny gut fungi could be the key to treating Asthma worldwide – The Brighter Side of News
eczemarelief
June 24, 2026